BeiGene
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
LATEST
CDC Awards $3 Million to Louisiana Breast and Cervical Health Program for Cancer Screenings
2026-08-12
JAMA Pediatrics Study Finds Hospital-Wide Documentation of Curbside Consultations Improves Patient Safety
2026-08-12
iNaturalist Photographs Help Researchers Double Known Number of Harvestman Species Exhibiting Parental Care
2026-08-12
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




